Bayer is a global life sciences leader in healthcare and nutrition. Building on a 150-year legacy in healthcare, Bayer is committed to improving patient lives by developing therapies and delivering first-in-class educational and support programs to meet their needs.
This information has been reviewed according to the US law and is consistent with US Prescribing Information and is intended for US audience only. Prescribing Information may vary depending on local approval in each country.
Click here to learn more about Xofigo (radium Ra 223 dichloride)
Click here to learn more about NUBEQA (darolutamide)
For additional information, contact:
Rebecca Cowens-Alvarado, MPH
Deputy Director Advocacy Relations
Erleada
Prescribing Information:
Financial Resources:
Paying for ERLEADA:
https://www.erleada.com/paying-for-erleada
Know Your State Interactive Tool:
https://www.janssencarepath.com/sites/www.janssencarepath-v1.com/files/know-your-state.pdf
EDUCATIONAL RESOURCES
Living With Cancer Website:
https://www.thisislivingwithcancer.com/living-with-app
Pfizer Virtual Booth:
http://pfizeroncologycongressresources.com
Living With Cancer iTunes App:
https://apps.apple.com/us/app/id1223073769
Know Your Prostate Plan – Patient Videos
Click here for Full Prescribing Information
PROVENGE
Prescribing Information:
https://www.provengehcp.com/Portals/5/Provenge-PI.pdf
Other Resources:
Provenge Support Information
https://www.provenge.com/Support
Your Provenge Experience:
POSLUMA
https://www.posluma.com/patient/
Patient Brochure:
https://www.posluma.com/patient-brochure.pdf
Advocacy Website:
Home page | Blue Earth Diagnostics Prostate Cancer (prostatecancer-blueearthdx.com)
CLICK HERE TO DOWNLOAD THE BROCHURE
PROSTOX genetic tests help prostate cancer patients choose the safest form of radiation treatment
These tests predict a patient’s risk of late, long-term side effects following two radiation treatment approaches for prostate cancer, based on the number of fractions a patient will receive:
PROSTOX ultra: for 5-7 fractions (sessions) given over 10 days, and called stereotactic body radiotherapy (SBRT)
PROSTOX CFRT: for 35-45 fractions (sessions) given over 8-10 weeks
Patient Information and Access
Find out if you’re eligible to access PROSTOX testing through MiraKind and learn more: https://mirakind.org/prostox-testing/
Clinical evidence and Information for physicians
Prolaris Explainer Video
Gary’s Prolaris Patient Testimonial
FoundationOne CDx
Patient Report Guide:
FoundationOne LiquidCDx
Patient Report Guide:
Patient Brochure:
https://www.foundationmedicine.com/sites/default/files/document/Patient_Booklet.pdf
PAN FOUNDATION
We help underinsured people with life-threatening, chronic and rare diseases get the medications and treatments they need by assisting with their out-of-pocket costs and advocating for improved access and affordability.
RESOURCES:
The PAN Foundation: https://www.panfoundation.org/
Our disease funds: https://www.panfoundation.org/find-disease-fund/
Find patient assistance in minutes! Sign up for FundFinder: https://fundfinder.panfoundation.org/
Become an advocate: https://www.panfoundation.org/become-an-advocate/